ARTICLE | Company News
Exeter Life Sciences Inc., PPL, Revivicor Holdings Inc. deal
March 1, 2004 8:00 AM UTC
PTH sold its gene-targeting IP to Exeter for £80,000 ($148,800). The IP relates to the production of proteins for use in pharmaceuticals and nutraceuticals. ...